MITOLA, STEFANIA MARIA FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 10.991
EU - Europa 9.294
AS - Asia 5.970
SA - Sud America 1.044
AF - Africa 145
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 7
Totale 27.540
Nazione #
US - Stati Uniti d'America 10.801
PL - Polonia 5.079
CN - Cina 1.961
SG - Singapore 1.913
IT - Italia 925
BR - Brasile 861
UA - Ucraina 826
DE - Germania 620
VN - Vietnam 607
HK - Hong Kong 577
FI - Finlandia 453
GB - Regno Unito 321
FR - Francia 280
IN - India 194
TR - Turchia 184
RU - Federazione Russa 170
IE - Irlanda 160
ID - Indonesia 103
CA - Canada 92
AU - Australia 83
BD - Bangladesh 81
ES - Italia 76
SE - Svezia 72
AR - Argentina 67
NL - Olanda 65
MX - Messico 58
ZA - Sudafrica 50
IQ - Iraq 49
BE - Belgio 48
CZ - Repubblica Ceca 46
JP - Giappone 44
AT - Austria 31
PK - Pakistan 27
EC - Ecuador 26
VE - Venezuela 23
CL - Cile 21
MA - Marocco 21
UZ - Uzbekistan 20
SA - Arabia Saudita 19
NG - Nigeria 17
EG - Egitto 16
AE - Emirati Arabi Uniti 15
CO - Colombia 15
IR - Iran 15
MY - Malesia 15
TW - Taiwan 15
JO - Giordania 14
CH - Svizzera 13
GR - Grecia 13
KR - Corea 13
DZ - Algeria 12
IL - Israele 12
PH - Filippine 12
PY - Paraguay 12
AZ - Azerbaigian 11
KE - Kenya 11
LT - Lituania 11
EE - Estonia 9
JM - Giamaica 9
BG - Bulgaria 8
HU - Ungheria 8
KG - Kirghizistan 8
NO - Norvegia 8
NP - Nepal 8
AL - Albania 7
EU - Europa 7
KZ - Kazakistan 7
PE - Perù 7
UY - Uruguay 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
HN - Honduras 6
LK - Sri Lanka 6
OM - Oman 6
PA - Panama 6
RO - Romania 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
ET - Etiopia 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
BO - Bolivia 4
BY - Bielorussia 4
LA - Repubblica Popolare Democratica del Laos 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
AM - Armenia 3
CR - Costa Rica 3
HR - Croazia 3
LV - Lettonia 3
MD - Moldavia 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
KW - Kuwait 2
LB - Libano 2
MU - Mauritius 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
Totale 27.512
Città #
Warsaw 5.073
Ashburn 1.097
Fairfield 1.087
Singapore 1.039
Woodbridge 719
Houston 684
Jacksonville 610
Hong Kong 571
San Jose 533
Ann Arbor 495
Brescia 453
Seattle 450
Cambridge 419
Chandler 385
Beijing 384
Wilmington 363
Princeton 279
Helsinki 277
The Dalles 268
New York 251
Dong Ket 241
Council Bluffs 229
Los Angeles 204
Nanjing 199
Dearborn 198
Dublin 154
Lauterbourg 144
Istanbul 141
Dallas 140
Ho Chi Minh City 119
Munich 119
Milan 102
São Paulo 102
Shanghai 86
Buffalo 82
Jakarta 81
Nanchang 77
Des Moines 75
Hanoi 70
Jinan 70
San Francisco 70
Shenyang 65
Changsha 63
Chicago 62
Turku 60
Hebei 59
Orem 55
Hangzhou 54
Moscow 54
Phoenix 54
Santa Clara 52
Madrid 51
San Diego 49
London 48
Brussels 46
Redondo Beach 45
Jiaxing 37
Tianjin 36
Boardman 34
Chennai 34
Tokyo 34
Toronto 34
Guangzhou 33
Brooklyn 32
Frankfurt am Main 31
Stockholm 31
Amsterdam 30
Kunming 30
Atlanta 29
Johannesburg 29
Melbourne 29
Zhengzhou 29
Nuremberg 28
Haikou 27
Porto Alegre 27
Montreal 26
Denver 25
Lancaster 25
Lappeenranta 25
Rio de Janeiro 25
Boston 24
Washington 23
Manchester 22
Ningbo 22
Poplar 21
Rome 21
Brno 20
Da Nang 20
Curitiba 19
Dhaka 19
Lanzhou 19
San Mateo 19
Ankara 18
Olomouc 18
Tashkent 18
Abuja 17
Belo Horizonte 17
Mexico City 17
Mumbai 17
Augusta 16
Totale 20.064
Nome #
Tumor angiogenesis revisited: Regulators and clinical implications 410
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. 395
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 372
Annexin 2A sustains glioblastoma cell dissemination and proliferation. 369
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 343
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 317
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 311
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 309
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice 304
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 302
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 302
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 298
Claudin3 is localized outside the tight junctions in human carcinomas 290
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 287
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 285
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 282
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 282
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. 279
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 279
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 278
Regulation of dendritic cell migration and adaptive immune response by leukotriene b4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function 276
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 272
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 271
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 270
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 267
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 266
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 264
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. 261
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 254
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 253
Integrins: A flexible platform for endothelial vascular tyrosine kinase receptors. 252
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 248
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 245
Interactions between endothelial cells and HIV-1. 242
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 240
Involvement of chemokine receptor4/ cell-derived factor 1 system during osteosarcoma tumor progression 238
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 238
Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. 237
Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. 234
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. 230
Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. 228
Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. 228
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 228
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 225
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 223
Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. 219
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 217
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 215
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative.Effect on the motility of vascular endothelial cells. 212
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 212
Preliminary observations on scleral ossicles in performing functionalized 3D vascularized scaffolds for “critical-size” bone defect healing 212
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 207
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 203
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 199
Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis 199
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 197
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 196
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 191
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 191
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 187
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 185
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 185
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 185
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 184
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 181
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 178
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 173
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 170
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process 161
Insights on the receptor dynamics during the spreading of endothelial cells 160
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 159
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 159
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 159
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 156
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 156
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 155
Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. 153
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 151
Bartonella henselae Persistence within Mesenchymal Stromal Cells Enhances Endothelial Cells Activation and Infectability Amplifying the Angiogenic Process 149
IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. 148
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 146
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 146
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 146
CCL16 activates an angiogenic program in vascular endothelial cells 145
Simulation of VEGF receptor recruitment on ECs membrane 145
Vascular disrupting activity of combretastatin analogues 144
Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. 142
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 142
Fibroblast growth factor-2 in angiogenesis 141
Gremlin as a novel pro-angiogenic VEGFR2 agonist: production of a biologically active recombinant form in S2 Drosophila cells 141
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 141
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 138
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 137
Dendritic cell-endothelial cell cross-talk in angiogenesis. 136
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 135
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 134
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 134
Role of VEGFs in metabolic disorders 133
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels 132
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 131
Totale 21.637
Categoria #
all - tutte 101.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021890 0 0 0 0 0 0 0 0 0 302 274 314
2021/20221.291 81 244 27 28 37 69 74 72 67 176 103 313
2022/20231.191 198 78 61 69 90 276 22 103 166 15 42 71
2023/20241.607 85 71 154 124 91 243 60 101 295 119 40 224
2024/20253.248 69 25 38 485 363 252 291 141 394 200 572 418
2025/20267.115 650 851 527 1.002 759 535 1.253 372 575 591 0 0
Totale 27.914